NASDAQ:ALEC Alector (ALEC) Stock Price, News & Analysis $1.76 +0.06 (+3.53%) Closing price 04:00 PM EasternExtended Trading$1.76 0.00 (0.00%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Alector Stock (NASDAQ:ALEC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Alector alerts:Sign Up Key Stats Today's Range$1.72▼$1.8050-Day Range$1.61▼$2.2152-Week Range$1.55▼$7.58Volume400,407 shsAverage Volume603,652 shsMarket Capitalization$172.36 millionP/E RatioN/ADividend YieldN/APrice Target$3.75Consensus RatingHold Company OverviewAlector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.Read More… Alector Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreALEC MarketRank™: Alector scored higher than 77% of companies evaluated by MarketBeat, and ranked 270th out of 959 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingAlector has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 3 buy ratings, 2 hold ratings, and 2 sell ratings.Amount of Analyst CoverageAlector has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Alector's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Alector are expected to decrease in the coming year, from ($1.88) to ($1.98) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alector is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alector is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlector has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Alector's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.25% of the float of Alector has been sold short.Short Interest Ratio / Days to CoverAlector has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in Alector has recently increased by 1.61%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlector does not currently pay a dividend.Dividend GrowthAlector does not have a long track record of dividend growth. Sustainability and ESG4.5 / 5Environmental Score-0.92 Percentage of Shares Shorted7.25% of the float of Alector has been sold short.Short Interest Ratio / Days to CoverAlector has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in Alector has recently increased by 1.61%, indicating that investor sentiment is decreasing. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Alector this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for ALEC on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Alector to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Alector insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $239,806.00 in company stock.Percentage Held by InsidersOnly 9.10% of the stock of Alector is held by insiders.Percentage Held by Institutions85.83% of the stock of Alector is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alector's insider trading history. Receive ALEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter. Email Address ALEC Stock News HeadlinesAnalysts Set Alector, Inc. (NASDAQ:ALEC) Target Price at $3.75February 14, 2025 | americanbankingnews.comAlector stock hits 52-week low at $1.59 amid market challengesFebruary 3, 2025 | msn.comCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?February 18, 2025 | Investors Alley (Ad)Alector’s Strategic Advancements and Promising Pipeline: A Buy Rating by Thomas ShraderJanuary 22, 2025 | markets.businessinsider.comDiscovering 3 US Penny Stocks With Market Caps Below $200MJanuary 21, 2025 | finance.yahoo.comBTIG Remains a Buy on Alector (ALEC)January 16, 2025 | markets.businessinsider.comWhy AbbVie Stock is on SaleJanuary 15, 2025 | baystreet.caAlector (ALEC) Receives a Sell from Bank of America SecuritiesJanuary 14, 2025 | markets.businessinsider.comSee More Headlines ALEC Stock Analysis - Frequently Asked Questions How have ALEC shares performed this year? Alector's stock was trading at $1.89 on January 1st, 2025. Since then, ALEC shares have decreased by 6.9% and is now trading at $1.76. View the best growth stocks for 2025 here. How were Alector's earnings last quarter? Alector, Inc. (NASDAQ:ALEC) announced its quarterly earnings results on Wednesday, November, 6th. The company reported ($0.43) EPS for the quarter, beating the consensus estimate of ($0.53) by $0.10. The company earned $15.34 million during the quarter, compared to analyst estimates of $16.33 million. Alector had a negative net margin of 257.54% and a negative trailing twelve-month return on equity of 108.77%. Does Alector have any subsidiaries? Alector subsidiaries include these companies: Alector LLC. When did Alector IPO? Alector (ALEC) raised $177 million in an IPO on Thursday, February 7th 2019. The company issued 9,300,000 shares at a price of $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO. Who are Alector's major shareholders? Top institutional investors of Alector include RA Capital Management L.P. (9.90%), Geode Capital Management LLC (1.95%), JPMorgan Chase & Co. (1.68%) and Deutsche Bank AG (1.13%). Insiders that own company stock include Polaris Venture Management Co, Arnon Rosenthal, Sara Kenkare-Mitra, Robert King, Marc Grasso, Gary Romano and Paula Hammond. View institutional ownership trends. How do I buy shares of Alector? Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alector own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alector investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Enovix (ENVX), Meta Platforms (META), Rambus (RMBS), Saia (SAIA) and Tesla (TSLA). Company Calendar Last Earnings11/06/2024Today2/18/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ALEC CUSIPN/A CIK1653087 Webwww.alector.com Phone(415) 231-5660FaxN/AEmployees270Year Founded2013Price Target and Rating Average Stock Price Target$3.75 High Stock Price Target$7.00 Low Stock Price Target$1.00 Potential Upside/Downside+113.1%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.70) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-130,390,000.00 Net Margins-257.54% Pretax Margin-254.70% Return on Equity-108.77% Return on Assets-27.03% Debt Debt-to-Equity RatioN/A Current Ratio3.29 Quick Ratio3.29 Sales & Book Value Annual Sales$97.06 million Price / Sales1.78 Cash FlowN/A Price / Cash FlowN/A Book Value$1.41 per share Price / Book1.25Miscellaneous Outstanding Shares97,930,000Free Float89,021,000Market Cap$172.36 million OptionableOptionable Beta0.61 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:ALEC) was last updated on 2/18/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored50-year legend: Here’s exact day stocks will crashBig Study Shows Stocks Extremely Likely to Crash in 2026? Legendary quant analyst Marc Chaikin says in 50 y...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alector, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alector With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.